PET scans use a radioactive tracer to generate images of the body for medical analysis. Doctors commonly use PET scans to detect cancer and assess how far it has spread. Radiation exposure from PET ...
A heart PET scan is a noninvasive imaging test that uses a small amount of radiation. It helps doctors understand how the heart functions and whether it is healthy. Cardiac or heart PET scans create ...
A PET scan can help doctors spot cancer that has spread through the body. A doctor may request one during the melanoma diagnostic process if they suspect advanced melanoma cancer. A PET scan is an ...
Positron emission tomography (PET) is a type of imaging scan that doctors might use when diagnosing and treating non-Hodgkin’s lymphoma (NHL). It can be useful for identifying and staging the cancer.
Sayaka Blickenderfer is a medical and science editor and writer with more than 10 years of experience. She edits and prepares scientific manuscripts and grant proposals for submission. Jane Kim, MD, ...
PET scans were helpful in determining which patients with HER2-positive early breast cancer may be able to skip chemotherapy. Treating patients with HER2-positive early breast cancer based on positron ...
Dr George Owiti, a radiographer at Kericho County Hospital examines the Chest CT results of a patient admitted to the hospital. [James Wanzala, Standard] Despite recent breakthroughs that have ...
Preparing for a PET scan requires switching to a no-sugar diet the day before the scan. People with diabetes may have special instructions regarding medications. Doctors typically schedule PET scans ...
PSMA PET scans significantly enhance detection and staging of prostate cancer, improving patient stratification and survival outcomes. Three FDA-approved PSMA PET scans are available, aiding in both ...
A positron emission tomography (PET) scan is a diagnostic tool that examines body tissue functioning, such as blood flow, oxygen use, and sugar metabolism, to help doctors diagnose and treat disease.
For years, prostate cancer specialists hit a wall when prostate-specific antigen (PSA) levels crept up after definitive treatment. The cancer was likely back — but where? And to what extent? Bone plus ...